Here's What Key Metrics Tell Us About Bunge Global (BG) Q2 Earnings

Bunge Global (BG) reported mixed Q2 2025 results, with revenue of $12.77 billion and EPS of $1.31, both down year-over-year but significantly surpassing Zacks Consensus Estimates by 12.45% and 10.08% respectively. While Agribusiness volumes and EBIT exceeded analyst expectations, performance in Milling products and Refined & Specialty Oils segments was more varied against projections. Despite the earnings beat, BG shares have underperformed the broader market, returning -4.9% over the past month compared to the S&P 500's +3.4% gain, and currently hold a Zacks Rank #3 (Hold).

Analysis

Bunge Global's Q2 2025 financial results present a nuanced picture, characterized by significant beats on consensus estimates but contracting year-over-year performance. The company reported revenue of $12.77 billion and EPS of $1.31, which, while surpassing Wall Street's forecasts by 12.45% and 10.08% respectively, represent declines of 3.6% in revenue and 24.3% in EPS compared to the prior-year quarter. A deeper look into segment performance reveals this dichotomy was driven by the core Agribusiness division, where both volumes and Adjusted EBIT substantially exceeded analyst projections. Specifically, Agribusiness EBIT came in at $233 million against a $202.09 million estimate. However, this strength was offset by underperformance elsewhere; the Refined & Specialty Oils segment's Adjusted EBIT of $116 million was a notable miss against the $138.56 million estimate, and Milling products volumes also fell short of expectations. The market appears to be weighing the year-over-year deterioration and segment-specific weaknesses more heavily than the headline earnings surprise, as evidenced by the stock's -4.9% return over the past month, which significantly trails the S&P 500's +3.4% gain.

Key Decisions for Investors

• Investors should weigh the strong performance and estimate beat in the core Agribusiness segment against the clear underperformance and margin pressure in the Refined & Specialty Oils division.
• Given the stock's recent underperformance despite the earnings beat, a cautious approach is warranted; the market is signaling concern over the year-over-year declines and segment-specific weaknesses.
• Monitor future performance in the Milling and Specialty Oils segments for signs of stabilization or recovery, as improvement here could be a catalyst for a re-evaluation of the stock's current 'Hold' consensus.